[ET Net News Agency, 8 December 2023] CSTONE PHARMA-B (02616) rose 20.5% to HK$2.47,
breaking above the 100-D SMA of HK$2.163.
It hits an intra-day high of HK$2.48, and an intra-day low of HK$2, hitting an 1-month
low. The total shares traded was 6.55 million, with a value of HK$14.38m. The active
buy/sell ratio is 64:36, with net buying turnover of HK$3.78m. CHINA INV INFO accounts for
greatest net responsive buying turnover of HK$1.65m, with volume weighted average price of
HK$2.212. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling
turnover of HK$1.05m, with volume weighted average price of HK$2.196.
Basic Information
=================
---------------------------------
Nominal 2.470 % Chg +20.49%
High 2.480 Low 2.000
Shares Tr 6.55m Turnover 14.38m
10-D SMA 2.225 %H.V 57.994
20-D SMA 2.312 VWAP 2.194
50-D SMA 2.106 RSI14 59.814
---------------------------------
Status: Breaking above the 100-D SMA, hitting an 1-month low, active buy/sell ratio is
64:36, with net buying turnover of HK$3.78m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSTONE PHARMA-B (02616) 2.47 +20.49
HUTCHMED (00013) 30.00 +2.39
GENSCRIPT BIO (01548) 20.35 +0.49
INNOVENT BIO (01801) 39.45 -2.11
EVEREST MED-B (01952) 19.70 +0.20
KEYMED BIO-B (02162) 50.60 -6.04
WUXI BIO (02269) 29.25 -2.34
BEIGENE (06160) 107.30 -1.47
ZAI LAB (09688) 21.00 -1.18
AKESO (09926) 43.15 -1.93
-----------------------------------------------
(ed)